Actively Recruiting
Single-blinded Randomized Trial of Latex Versus Non-latex Hemorrhoid Banding
Led by Huntington Memorial Hospital · Updated on 2024-10-28
164
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the use of latex versus non-latex bands in rubber band ligation for adult patients with symptomatic grade 2-3 internal hemorrhoids. The study aims to compare how well non-latex bands perform compared to latex bands in treating these hemorrhoids and to assess related side effects such as pain, bleeding, and other complications both immediately and within three weeks after the procedure. Participants will be randomly assigned to receive hemorrhoid banding with either latex or non-latex bands. The treatments are applied during the banding procedure, and both types of bands will be studied to observe their effectiveness and any adverse events. The study is single-blinded and focuses on the comparison of these two types of banding devices. During the study, participants will be monitored over 2 to 4 months to measure the success of the hemorrhoid banding and to record any banding-related adverse effects. Researchers will collect data on pain, bleeding, and other complications following the banding procedure. The overall goal is to determine the safety and performance of non-latex bands compared to latex bands in this patient population.
CONDITIONS
Brief Title
Trial of Latex Vs Non-latex Hemorrhoid Banding
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults with symptomatic grade 2-3 internal hemorrhoids undergoing rubber band ligation
You will not qualify if you...
- Previous hemorrhoidal banding within the past year
- Known latex allergy
- Pregnancy
- Use of anticoagulation medication
- Bleeding disorder
- Portal hypertension
- Inflammatory bowel disease
- Immunosuppression
- Functional neurologic disorder
- Pelvic floor dysfunction
- Any records flagged "break the glass" or "research opt out"
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single treatment session
Participants receive hemorrhoid banding using either latex or non-latex bands as part of the treatment.
1 treatment visit (in-person)
Duration - Up to 3 weeks
Participants are monitored for banding-related adverse effects including pain, bleeding, and complications immediately and within 3 weeks following hemorrhoidal banding.
Approximately 2 follow-up visits (in-person)
Trial Site Locations
Total: 1 location
1
Huntington Memorial Hospital
Pasadena, California, United States, 91105
Actively Recruiting
Research Team
A
Adam Truong, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here